TABLE 1

Rate Constants, VT, and Goodness of Fit After P-gp Blockade, Using 1-Tissue-Compartment Model

Rate constantGoodness of fit
RegionK1 (mL·cm−3·min−1)k2 (min−1)VT (mL·cm−3)AICMSC
Frontal cortex0.201 ± 0.031 (1.1 ± 0.2)0.011 ± 0.004 (2.7 ± 0.7)21.1 ± 8.3 (1.9 ± 0.6)94 ± 94.1 ± 0.2
Anterior cingulate0.251 ± 0.048 (1.7 ± 0.5)0.011 ± 0.004 (3.9 ± 1.5)24.2 ± 9.6 (2.8 ± 1.1)121 ± 193.3 ± 0.5
Temporal cortex0.25 ± 0.032 (1.1 ± 0.3)0.011 ± 0.003 (2.6 ± 0.9)24.2 ± 8.7 (1.9 ± 0.7)96 ± 164 ± 0.4
Parietal cortex0.229 ± 0.036 (1.1 ± 0.2)0.011 ± 0.004 (2.4 ± 0.6)22.6 ± 9.1 (1.7 ± 0.4)93 ± 84.1 ± 0.1
Hippocampus0.236 ± 0.057 (1.9 ± 0.2)0.011 ± 0.003 (4.4 ± 1.0)22.7 ± 9.3 (3.1 ± 0.9)132 ± 72.8 ± 0.4
Occipital cortex0.233 ± 0.035 (1.0 ± 0.2)0.012 ± 0.005 (2.2 ± 0.7)22.3 ± 9.4 (1.6 ± 0.6)86 ± 134.4 ± 0.4
Putamen0.331 ± 0.040 (1.0 ± 0.2)0.011 ± 0.004 (2.2 ± 0.6)31.7 ± 12.4 (1.6 ± 0.5)87 ± 104.4 ± 0.2
Cerebellum0.314 ± 0.051 (1.2 ± 0.4)0.014 ± 0.004 (2.4 ± 0.9)24.2 ± 9.3 (1.8 ± 0.7)102 ± 233.9 ± 0.8
  • AIC = Akaike information criterion; MSC = model selection criterion.

  • P-gp was blocked by DCPQ (8 mg/kg, intravenously) administered 30 min before injection of 11C-dLop. For each brain region, identifiability is listed in parentheses and is expressed as percentage of variable itself. Values are mean ± SD from 4 monkeys.